PMID- 23512667 OWN - NLM STAT- MEDLINE DCOM- 20141023 LR - 20211021 IS - 1099-0844 (Electronic) IS - 0263-6484 (Print) IS - 0263-6484 (Linking) VI - 32 IP - 1 DP - 2014 Jan TI - Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo. PG - 39-50 LID - 10.1002/cbf.2969 [doi] AB - AIMS: Muscle ring finger (MuRF) proteins have been implicated in the transmission of mechanical forces to nuclear cell signaling pathways through their association with the sarcomere. We recently reported that MuRF1, but not MuRF2, regulates pathologic cardiac hypertrophy in vivo. This was surprising given that MuRF1 and MuRF2 interact with each other and many of the same sarcomeric proteins experimentally. METHODS AND RESULTS: Mice missing all four MuRF1 and MuRF2 alleles [MuRF1/MuRF2 double null (DN)] were born with a massive spontaneous hypertrophic cardiomyopathy and heart failure; mice that were null for one of the genes but heterozygous for the other (i.e. MuRF1(-/-) //MuRF2(+/-) or MuRF1(+/-) //MuRF2(-/-) ) were phenotypically identical to wild-type mice. Microarray analysis of genes differentially-expressed between MuRF1/MuRF2 DN, mice missing three of the four alleles and wild-type mice revealed a significant enrichment of genes regulated by the E2F transcription factor family. More than 85% of the differentially-expressed genes had E2F promoter regions (E2f:DP; P<0.001). Western analysis of E2F revealed no differences between MuRF1/MuRF2 DN hearts and wild-type hearts; however, chromatin immunoprecipitation studies revealed that MuRF1/MuRF2 DN hearts had significantly less binding of E2F1 in the promoter regions of genes previously defined to be regulated by E2F1 (p21, Brip1 and PDK4, P<0.01). CONCLUSIONS: These studies suggest that MuRF1 and MuRF2 play a redundant role in regulating developmental physiologic hypertrophy, by regulating E2F transcription factors essential for normal cardiac development by supporting E2F localization to the nucleus, but not through a process that degrades the transcription factor. CI - Copyright (c) 2013 John Wiley & Sons, Ltd. FAU - Willis, Monte S AU - Willis MS AD - McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, USA; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA. FAU - Wadosky, Kristine M AU - Wadosky KM FAU - Rodriguez, Jessica E AU - Rodriguez JE FAU - Schisler, Jonathan C AU - Schisler JC FAU - Lockyer, Pamela AU - Lockyer P FAU - Hilliard, Eleanor G AU - Hilliard EG FAU - Glass, David J AU - Glass DJ FAU - Patterson, Cam AU - Patterson C LA - eng GR - R37HL065619/HL/NHLBI NIH HHS/United States GR - T32 HL069768/HL/NHLBI NIH HHS/United States GR - T32 HL083828/HL/NHLBI NIH HHS/United States GR - R01 HL065619/HL/NHLBI NIH HHS/United States GR - R01 HL104129/HL/NHLBI NIH HHS/United States GR - R37 HL065619/HL/NHLBI NIH HHS/United States GR - R01HL104129/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130320 PL - England TA - Cell Biochem Funct JT - Cell biochemistry and function JID - 8305874 RN - 0 (E2F1 Transcription Factor) RN - 0 (E2f1 protein, mouse) RN - 0 (Muscle Proteins) RN - 0 (Tripartite Motif Proteins) RN - 0 (muscle RING finger 2 protein, mouse) RN - EC 2.3.2.27 (Trim63 protein, mouse) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) SB - IM MH - Animals MH - Animals, Newborn MH - Cardiomegaly/genetics/*metabolism MH - E2F1 Transcription Factor/genetics/metabolism MH - Gene Expression MH - Heart/growth & development/*physiology MH - Mice MH - Mice, Knockout MH - Muscle Proteins/genetics/*metabolism MH - Promoter Regions, Genetic MH - Sarcomeres/metabolism MH - Tripartite Motif Proteins MH - Ubiquitin-Protein Ligases/genetics/*metabolism PMC - PMC3728166 MID - NIHMS460310 OTO - NOTNLM OT - E2F OT - MuRF1 OT - MuRF2 OT - cardiac hypertrophy OT - ubiquitin ligase COIS- Conflict of Interest The authors have declared that no conflict of interest exists (M.W., J.R., K.W., J.S.,P.L., E.H., D.G., C.P.). EDAT- 2013/03/21 06:00 MHDA- 2014/10/24 06:00 PMCR- 2015/01/01 CRDT- 2013/03/21 06:00 PHST- 2012/10/02 00:00 [received] PHST- 2013/02/03 00:00 [revised] PHST- 2013/02/14 00:00 [accepted] PHST- 2013/03/21 06:00 [entrez] PHST- 2013/03/21 06:00 [pubmed] PHST- 2014/10/24 06:00 [medline] PHST- 2015/01/01 00:00 [pmc-release] AID - 10.1002/cbf.2969 [doi] PST - ppublish SO - Cell Biochem Funct. 2014 Jan;32(1):39-50. doi: 10.1002/cbf.2969. Epub 2013 Mar 20.